PPARγ与骨量丢失
出处
《河北医药》
CAS
2007年第2期153-154,共2页
Hebei Medical Journal
基金
河北省重点医学适用技术跟踪项目(92004-25)
河北省科技领军人才基金项目(06547008D-2)
河北省科技厅重大疾病及创新药物专项(06276106D)
参考文献23
-
1Akune T,Ohba S,Kamekura S,et al.PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors.J Clin Invest,2004,113:846-855.
-
2Rzonca SO,Suva LJ,Gaddy D,et al.Bone is a target for the antidiabetic compound rosiglitazone.Endocrinology,2004,145:401-406.
-
3Jilka RL,Lecka-Czernik B,Ali AA,et al.Activation of PPAR 2 by rosiglitazone causes bone loss associated with increased marrow adiposity and decreased osteoblast number in mice.J Bone Miner Res,2001,16:S319.
-
4Jackson SM,Demer LL.Peroxisome proliferator-activated receptor activators modulate the osteoblastic maturation of MC3T3-E1 preosteoblasts.FEBS Lett,2000,471:119-124.
-
5Lecka-Czernik B,Moerman EJ,Grant DF,et al.Divergent effects of selective peroxisome proliferator-activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation.Endocrinology,2002,143:2376-2384.
-
6Tornvig L,Mosekilde LJ,Justesen J,et al.Troglitazone treatment increases bone marrow adipose tissue volume but does not affect trabecular bone volume in mice.Calcif Tissue Int,2001,69:46-50.
-
7Ali AA,Weinstein RS,Stewart SA,et al.Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation.Endocrinology,2005,146:1226-1235.
-
8Soroceanu MA,Miao D,Bai XY,et al.Rosiglitazone impacts negatively on bone by promoting osteoblast/osteocyte apoptosis.J Endocrinology,2004,183:203-216.
-
9Wagner EF,Karsenty G.Genetic control of skeletal development.Curr Opin Genet Dev,2001,11:527-532.
-
10Nakashima K,Zhou X,Kunkel G,et al.The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation.Cell,2002,108:17-29.
-
1脂肪代谢障碍[J].国外科技资料目录（医药卫生）,2002(6):62-63.
-
2裘玲霞.吡格列酮对2型糖尿病患者血脂、血糖的影响[J].浙江临床医学,2006,8(2):156-156.
-
3宋树芬,刘树嘉.69例老年人流行性出血热多器官功能衰竭临床分析[J].青岛医药卫生,1996,28(5):5-6.
-
4高一凯,菅向东,张莉,王珂.急性百草枯中毒合并室上速及糖尿病酮症酸中毒1例[J].中国工业医学杂志,2015,28(6):429-430.
-
5邓卓军,赵彩彦.过氧化物酶体增殖物激活受体α与非酒精性脂肪性肝炎[J].国外医学（消化系疾病分册）,2005,25(5):275-278. 被引量：1
-
6姚园,江洪.过氧化物酶体增殖物激活受体γ的心血管保护作用[J].岭南心血管病杂志,2006,12(6):445-448. 被引量：3
-
7陆翠华,张忠兵,陈岳祥.血小板源生长因子在肝星状细胞内的信号转导机制[J].国外医学（生理病理科学与临床分册）,2001,21(6):469-471. 被引量：2
-
8邹雄.心脑血管病基因研究进展[J].国外医学（临床生物化学与检验学分册）,2003,24(3):125-126. 被引量：2
-
9于尧,肖君刚.过敏性紫癜患者IL-23/IL-17轴相关因子的检测[J].中国皮肤性病学杂志,2014,28(3):260-262. 被引量：4
-
10王萍.血小板衍生生长因子与肝纤维化[J].国外医学（消化系疾病分册）,2000,20(1):40-43. 被引量：9
